We are live on ! Find out more
RVPH

REVIVA PHARMA HLDGS INC
RVPH

Delisted

RVPH was delisted on the 13th of May, 2026.

Back to rankings

48 hedge funds and large institutions have $6.95M invested in REVIVA PHARMA HLDGS INC in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

14% more funds holding

Funds holding: 42 → 48 (+6)

0.04% less ownership

Funds ownership: 0.83% → 0.79% (-0.04%)

45% less call options, than puts

Call options by funds: $2.25M | Put options by funds: $4.13M

50% less capital invested

Capital invested by funds: $14M → $6.95M (-$7.06M)

Holders
48
Holders Change
+6
Holders Change %
+14.29%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
11
Reduced
8
Closed
12
Calls
$2.25M
Puts
$4.13M
Net Calls
-$1.87M
Net Calls Change
-$3.02M

Top Buyers

Rank Fund Capital Flow
1
DP
Diadema Partners
New Jersey
+$1.02M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$659K
3
TCM
Tang Capital Management
California
+$535K
4
UBS Group
UBS Group
Switzerland
+$351K
5
Marshall Wace
Marshall Wace
United Kingdom
+$340K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$2.47M
2
SSA
Schonfeld Strategic Advisors
New York
-$1.26M
3
PHP
Parkman Healthcare Partners
Connecticut
-$931K
4
Millennium Management
Millennium Management
New York
-$425K
5
Ameriprise
Ameriprise
Minnesota
-$84.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$17K +$7.07K +225 +35%
CSA
27
Cornerstone Select Advisors
Missouri
$16.7K – – –
Raymond James Financial
28
Raymond James Financial
Florida
$14.4K +$1.79K +57 +8%
Charles Schwab
29
Charles Schwab
California
$14.3K +$23.6K +750 New
JF
30
Jump Financial
Illinois
$12K +$19.8K +630 New
NWM
31
NRI Wealth Management
California
$11.8K – – –
VF
32
Virtu Financial
New York
$11K +$17.8K +565 New
SA
33
Sanctuary Advisors
Indiana
$10.5K +$17.3K +550 New
IAS
34
Insigneo Advisory Services
Florida
$9.54K +$15.7K +500 New
Northwestern Mutual Wealth Management
35
Northwestern Mutual Wealth Management
Wisconsin
$8.87K – – –
TRCT
36
Tower Research Capital (TRC)
New York
$7.87K -$29.1K -927 -69%
IA
37
IFP Advisors
Florida
$4.67K – – –
Morgan Stanley
38
Morgan Stanley
New York
$3.93K -$3.14K -100 -33%
Citadel Advisors
39
Citadel Advisors
Florida
$3.2K +$5.28K +168 New
Wells Fargo
40
Wells Fargo
California
$2.86K +$4.71K +150 New
CIAM
41
Caitong International Asset Management
Hong Kong
$1.16K +$1.92K +61 New
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$1K – – –
AWM
43
Activest Wealth Management
Florida
$954 – – –
Jones Financial Companies
44
Jones Financial Companies
Missouri
$848 – – –
Bank of America
45
Bank of America
North Carolina
$335 +$63 +2 +13%
TWC
46
TD Waterhouse Canada
Ontario, Canada
$306 +$786 +25 New
TCM
47
Tradewinds Capital Management
Washington
$239 – – –
Fidelity Investments
48
Fidelity Investments
Massachusetts
$191 +$314 +10 New
Barclays
49
Barclays
United Kingdom
$6 – – –
AC
50
Armistice Capital
New York
– -$2.47M -68,200 Closed
1
2
3

RVPH Hedge Fund Activity: Q1 2025 in Review

48 of the 7,464 institutional investors tracked by Wall St. Rank reported a position in REVIVA PHARMA HLDGS INC (RVPH) for Q1 2025, worth a combined $6.95M — down 50% from $14M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new RVPH positions and 12 closed out — a net gain of 6 holders — while 11 added to existing stakes and 8 trimmed.

The largest buyer was Diadema Partners, opening a new position worth an estimated $1.02M. The largest seller was Armistice Capital, exiting entirely with an estimated $2.47M sold.

  • 48 institutional investors held REVIVA PHARMA HLDGS INC (RVPH) as of Q1 2025, up from 42 in Q4 2024.
  • Funds reported $6.95M of REVIVA PHARMA HLDGS INC stock for Q1 2025, down 50% quarter-over-quarter.
  • 18 funds opened new REVIVA PHARMA HLDGS INC positions in Q1 2025 and 12 closed out, a net change of +6 holders.
  • The largest REVIVA PHARMA HLDGS INC buyer in Q1 2025 was Diadema Partners, an estimated $1.02M added.
  • The largest REVIVA PHARMA HLDGS INC seller in Q1 2025 was Armistice Capital, an estimated $2.47M sold.

Based on aggregated 13F filings for Q1 2025.